Results 231 to 240 of about 22,884 (253)

The Committee for Orphan Medicinal Products of the EMEA has granted orphan drug status to maribavir

Inpharma Weekly, 2007
openaire   +1 more source

The Food and Drug Administration’s Office of Orphan Products Development: Incentives, Grants, and Special Designations Speed Therapies for Orphan Diseases

Retina, 2005
openaire   +2 more sources

Issues Aired Related to Orphan Drug Products at Washington Hearing

American Journal of Health-System Pharmacy, 1983
openaire   +1 more source

Are orphan drug companies the pick of the pharmaceutical industry?

Nature Reviews Drug Discovery, 2013
Thomas Morel, Steven Simoens
exaly  

A comparative study of European rare disease and orphan drug markets

Health Policy, 2010
Lut Mergaert, Steven Simoens
exaly  

The US Orphan Drug Programme 1983-1995

Pharmacoeconomics, 2012
Michael Manocchia
exaly  

Review of regulatory recommendations for orphan drug submissions in the netherlands and scotland: focus on the underlying pharmacoeconomic evaluations

Clinical Therapeutics, 2010
Stefan Vegter, Mark H Rozenbaum, Maarten J Postma   +2 more
exaly  

Evergreening exclusive rights in pharmaceutical products: the case of SPCs, paediatric extensions and orphan drugs

2022
openaire   +1 more source

Does orphan drug legislation really answer the needs of patients?

Lancet, The, 2008
Marlene E Haffner, Josep Torrent-Farnell   +1 more
exaly  

The Economics of Orphan Drug Policy in the US

Pharmacoeconomics, 2012
John W Peabody, Peabody John W
exaly